BI Asset Management Fondsmaeglerselskab A S Acquires 26,812 Shares of CME Group Inc. $CME

BI Asset Management Fondsmaeglerselskab A S increased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 167.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,781 shares of the financial services provider’s stock after purchasing an additional 26,812 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in CME Group were worth $11,559,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of CME Group by 1.5% during the second quarter. Vanguard Group Inc. now owns 35,176,376 shares of the financial services provider’s stock worth $9,695,313,000 after acquiring an additional 532,549 shares during the last quarter. Geode Capital Management LLC lifted its stake in CME Group by 3.6% in the 2nd quarter. Geode Capital Management LLC now owns 9,178,681 shares of the financial services provider’s stock worth $2,524,271,000 after purchasing an additional 319,899 shares in the last quarter. Norges Bank bought a new position in shares of CME Group during the 2nd quarter valued at about $1,571,447,000. Ameriprise Financial Inc. boosted its holdings in shares of CME Group by 2.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 4,682,066 shares of the financial services provider’s stock valued at $1,289,910,000 after purchasing an additional 92,925 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its position in shares of CME Group by 6.6% during the second quarter. Arrowstreet Capital Limited Partnership now owns 3,833,090 shares of the financial services provider’s stock valued at $1,056,476,000 after purchasing an additional 238,522 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CME. Rothschild & Co Redburn boosted their target price on CME Group from $297.00 to $300.00 and gave the stock a “neutral” rating in a research report on Thursday, November 6th. TD Cowen upped their price objective on CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a report on Thursday. Jefferies Financial Group lowered their target price on CME Group from $304.00 to $302.00 and set a “buy” rating for the company in a research report on Monday, January 12th. Raymond James Financial reduced their price target on shares of CME Group from $311.00 to $310.00 and set an “outperform” rating on the stock in a research report on Wednesday. Finally, JPMorgan Chase & Co. increased their price objective on shares of CME Group from $262.00 to $266.00 and gave the company an “underweight” rating in a research report on Thursday. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $295.82.

CME Group Stock Up 0.9%

NASDAQ CME opened at $297.38 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. The company has a fifty day moving average of $276.48 and a two-hundred day moving average of $272.84. The firm has a market capitalization of $107.24 billion, a price-to-earnings ratio of 26.65, a PEG ratio of 3.32 and a beta of 0.27. CME Group Inc. has a 52 week low of $239.70 and a 52 week high of $302.20.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating the consensus estimate of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the firm posted $2.52 earnings per share. The business’s revenue for the quarter was up 8.1% on a year-over-year basis. On average, analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

Insider Activity at CME Group

In other news, CEO Terrence A. Duffy sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the transaction, the chief executive officer owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. This represents a 27.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director William R. Shepard purchased 251 shares of the firm’s stock in a transaction that occurred on Tuesday, December 30th. The shares were acquired at an average cost of $278.37 per share, with a total value of $69,870.87. Following the completion of the purchase, the director directly owned 258,710 shares in the company, valued at $72,017,102.70. The trade was a 0.10% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.30% of the stock is owned by insiders.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Q4 results and record annual figures: CME posted Q4 EPS of $2.77 and revenue of ~$1.65B, with record 2025 annual revenue of $6.5B and all-time-high average daily volume in Q4 — fundamental beat that supports revenue resilience and margin strength. CME Group Q4 Earnings and Revenues Top Estimates, ADV Rises Y/Y
• Positive Sentiment: Management guidance and strategy: Management said fee adjustments could lift revenue ~1%–1.5% and reiterated plans to expand 24/7 crypto and securities clearing — a structural growth lever if adoption ramps. CME targets 1%-1.5% revenue lift; expanding 24/7 crypto
• Positive Sentiment: Morgan Stanley maintains Buy: A Wall Street analyst reiterated a Buy / Overweight view citing CME’s resilient fee-based franchise and underappreciated structural growth, supporting medium‑term upside. Morgan Stanley maintains Buy
• Neutral Sentiment: RBC raises price target modestly to $302 (sector perform): a small lift in analyst valuation but not a clear catalyst given the modest upside. RBC raises PT to $302
• Neutral Sentiment: Raymond James trims price target slightly to $310 but keeps Outperform — minimal change to the investment thesis. Raymond James adjusts PT to $310
• Neutral Sentiment: CEO says firm is exploring a proprietary token and tokenized cash pilots (with Google) to enable faster collateral movement and potential 24/7 trading — strategically important but execution, regulatory and adoption risks leave near-term impact uncertain. CME exploring issuing token
• Negative Sentiment: JPMorgan keeps an Underweight rating and has a $266 target (below current levels), signaling downside risk if volumes or product adoption slow relative to expectations. JPMorgan maintains Underweight, PT $266
• Negative Sentiment: Analyst caution / valuation note: a Seeking Alpha piece argues quality doesn’t automatically justify a buy today — a reminder that valuation and long-term growth execution should be assessed before adding exposure. CME Group: Quality Shines Through, But It Doesn’t Mean To Buy

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.